Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients

There is limited knowledge of influenza‐specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of immunology 2021-08, Vol.94 (2), p.e13045-n/a
Hauptverfasser: Paramsothy, Abira, Lartey Jalloh, Sarah, Davies, Richard A., Guttormsen, Anne‐Berit, Cox, Rebecca J., Mohn, Kristin G.‐I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 2
container_start_page e13045
container_title Scandinavian journal of immunology
container_volume 94
creator Paramsothy, Abira
Lartey Jalloh, Sarah
Davies, Richard A.
Guttormsen, Anne‐Berit
Cox, Rebecca J.
Mohn, Kristin G.‐I.
description There is limited knowledge of influenza‐specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to more severe illness. We followed 12 patients hospitalized with severe influenza infection; the majority admitted to intensive care unit (ICU). Blood samples were collected at days 10 and 19 and at 5 months. Antibody responses to surface glycoproteins haemagglutinin (HA) and neuraminidase (NA) of A/H1N1pdm09 were quantified by haemagglutination inhibition (HAI), microneutralization (MN), Enzyme‐linked immunosorbent assay (ELISA) and Enzyme‐linked lectin assay (ELLA). Influenza‐specific antibody levels and avidity were measured separately for head and stalk domains of H1. Cytokine secreting CD4+ and CD8+ T cell responses to conserved influenza epitopes (M1, NP and PB1) were analysed by FluoroSpot. Overall, the patients retained a high level of functional HA‐ and NA‐specific antibodies over the study period. During the acute phase (up to 3 weeks from symptom onset), antibodies specific to H1 stalk increased earlier and were present in higher amount compared with H1 head‐specific antibodies. The NA‐specific antibodies and the non‐neutralizing HA‐specific antibody response for H1 head and H1 full‐length showed a significant decline from acute to convalescent phase. Despite high total IgG concentrations, avidity to H1 head and H1 full‐length protein remained low at all time points. Similarly, CD8+ T cell responses were continuously measured at low levels. In conclusion, our study found that critically ill patients were characterized by low HA‐specific antibody avidity and CD8+ T cell response.
doi_str_mv 10.1111/sji.13045
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2518221040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2518221040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-5bdf4bbd822ce67affa245771ea773e6828ca7ba823e42961894d9b3d4cb32b23</originalsourceid><addsrcrecordid>eNp1kMtKw0AUhgdRtF4WvoAMuNFF2rk2k2UpaiuiC3UnhMnkBKZMkjqTIHXlI_iMPolTqy4Ez-bAz8fHOT9Cx5QMaZxRWNgh5UTILTSgfCwTThTfRgPCCUkykco9tB_CghDKWcp30R7nKqNcigF6mvV167XDuimxAed6pz22dd03gD2EZdsECNg22HjbWaOdW2HrXEwq10PzqvFkNKO39OPtPUZgOijxUncWmi4cop1KuwBH3_sAPV5ePExnyc3d1Xw6uUkMV0omsigrURSlYszAONVVpZmQaUpBpymHsWLK6LTQinEQLBtTlYkyK3gpTMFZwfgBOtt4l7597iF0eW3D-hndQNuHnEka3ZQIEtHTP-ii7X0Tr4uUZJRmmVKROt9QxrcheKjypbe19qucknxdeR4rz78qj-zJt7Evaih_yZ-OIzDaAC_Wwep_U35_Pd8oPwFzuYsr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2552119988</pqid></control><display><type>article</type><title>Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients</title><source>Access via Wiley Online Library</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Paramsothy, Abira ; Lartey Jalloh, Sarah ; Davies, Richard A. ; Guttormsen, Anne‐Berit ; Cox, Rebecca J. ; Mohn, Kristin G.‐I.</creator><creatorcontrib>Paramsothy, Abira ; Lartey Jalloh, Sarah ; Davies, Richard A. ; Guttormsen, Anne‐Berit ; Cox, Rebecca J. ; Mohn, Kristin G.‐I.</creatorcontrib><description>There is limited knowledge of influenza‐specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to more severe illness. We followed 12 patients hospitalized with severe influenza infection; the majority admitted to intensive care unit (ICU). Blood samples were collected at days 10 and 19 and at 5 months. Antibody responses to surface glycoproteins haemagglutinin (HA) and neuraminidase (NA) of A/H1N1pdm09 were quantified by haemagglutination inhibition (HAI), microneutralization (MN), Enzyme‐linked immunosorbent assay (ELISA) and Enzyme‐linked lectin assay (ELLA). Influenza‐specific antibody levels and avidity were measured separately for head and stalk domains of H1. Cytokine secreting CD4+ and CD8+ T cell responses to conserved influenza epitopes (M1, NP and PB1) were analysed by FluoroSpot. Overall, the patients retained a high level of functional HA‐ and NA‐specific antibodies over the study period. During the acute phase (up to 3 weeks from symptom onset), antibodies specific to H1 stalk increased earlier and were present in higher amount compared with H1 head‐specific antibodies. The NA‐specific antibodies and the non‐neutralizing HA‐specific antibody response for H1 head and H1 full‐length showed a significant decline from acute to convalescent phase. Despite high total IgG concentrations, avidity to H1 head and H1 full‐length protein remained low at all time points. Similarly, CD8+ T cell responses were continuously measured at low levels. In conclusion, our study found that critically ill patients were characterized by low HA‐specific antibody avidity and CD8+ T cell response.</description><identifier>ISSN: 0300-9475</identifier><identifier>EISSN: 1365-3083</identifier><identifier>DOI: 10.1111/sji.13045</identifier><identifier>PMID: 33891354</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antibodies ; Antibody response ; Avidity ; CD4 antigen ; CD8 antigen ; critical illness ; Enzyme-linked immunosorbent assay ; Enzymes ; Epitopes ; Exo-a-sialidase ; Glycoproteins ; Hemagglutination inhibition ; Hemagglutinins ; immune response ; Immune response (cell-mediated) ; Immune response (humoral) ; Immunoglobulin G ; Influenza ; Influenza A ; influenza A/H1N1 ; Lymphocytes ; Lymphocytes T</subject><ispartof>Scandinavian journal of immunology, 2021-08, Vol.94 (2), p.e13045-n/a</ispartof><rights>2021 The Scandinavian Foundation for Immunology</rights><rights>This article is protected by copyright. All rights reserved.</rights><rights>Copyright © 2021 The Scandinavian Foundation for Immunology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3885-5bdf4bbd822ce67affa245771ea773e6828ca7ba823e42961894d9b3d4cb32b23</citedby><cites>FETCH-LOGICAL-c3885-5bdf4bbd822ce67affa245771ea773e6828ca7ba823e42961894d9b3d4cb32b23</cites><orcidid>0000-0002-2304-2786 ; 0000-0002-3249-1719</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fsji.13045$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fsji.13045$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33891354$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paramsothy, Abira</creatorcontrib><creatorcontrib>Lartey Jalloh, Sarah</creatorcontrib><creatorcontrib>Davies, Richard A.</creatorcontrib><creatorcontrib>Guttormsen, Anne‐Berit</creatorcontrib><creatorcontrib>Cox, Rebecca J.</creatorcontrib><creatorcontrib>Mohn, Kristin G.‐I.</creatorcontrib><title>Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients</title><title>Scandinavian journal of immunology</title><addtitle>Scand J Immunol</addtitle><description>There is limited knowledge of influenza‐specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to more severe illness. We followed 12 patients hospitalized with severe influenza infection; the majority admitted to intensive care unit (ICU). Blood samples were collected at days 10 and 19 and at 5 months. Antibody responses to surface glycoproteins haemagglutinin (HA) and neuraminidase (NA) of A/H1N1pdm09 were quantified by haemagglutination inhibition (HAI), microneutralization (MN), Enzyme‐linked immunosorbent assay (ELISA) and Enzyme‐linked lectin assay (ELLA). Influenza‐specific antibody levels and avidity were measured separately for head and stalk domains of H1. Cytokine secreting CD4+ and CD8+ T cell responses to conserved influenza epitopes (M1, NP and PB1) were analysed by FluoroSpot. Overall, the patients retained a high level of functional HA‐ and NA‐specific antibodies over the study period. During the acute phase (up to 3 weeks from symptom onset), antibodies specific to H1 stalk increased earlier and were present in higher amount compared with H1 head‐specific antibodies. The NA‐specific antibodies and the non‐neutralizing HA‐specific antibody response for H1 head and H1 full‐length showed a significant decline from acute to convalescent phase. Despite high total IgG concentrations, avidity to H1 head and H1 full‐length protein remained low at all time points. Similarly, CD8+ T cell responses were continuously measured at low levels. In conclusion, our study found that critically ill patients were characterized by low HA‐specific antibody avidity and CD8+ T cell response.</description><subject>Antibodies</subject><subject>Antibody response</subject><subject>Avidity</subject><subject>CD4 antigen</subject><subject>CD8 antigen</subject><subject>critical illness</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>Epitopes</subject><subject>Exo-a-sialidase</subject><subject>Glycoproteins</subject><subject>Hemagglutination inhibition</subject><subject>Hemagglutinins</subject><subject>immune response</subject><subject>Immune response (cell-mediated)</subject><subject>Immune response (humoral)</subject><subject>Immunoglobulin G</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>influenza A/H1N1</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><issn>0300-9475</issn><issn>1365-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp1kMtKw0AUhgdRtF4WvoAMuNFF2rk2k2UpaiuiC3UnhMnkBKZMkjqTIHXlI_iMPolTqy4Ez-bAz8fHOT9Cx5QMaZxRWNgh5UTILTSgfCwTThTfRgPCCUkykco9tB_CghDKWcp30R7nKqNcigF6mvV167XDuimxAed6pz22dd03gD2EZdsECNg22HjbWaOdW2HrXEwq10PzqvFkNKO39OPtPUZgOijxUncWmi4cop1KuwBH3_sAPV5ePExnyc3d1Xw6uUkMV0omsigrURSlYszAONVVpZmQaUpBpymHsWLK6LTQinEQLBtTlYkyK3gpTMFZwfgBOtt4l7597iF0eW3D-hndQNuHnEka3ZQIEtHTP-ii7X0Tr4uUZJRmmVKROt9QxrcheKjypbe19qucknxdeR4rz78qj-zJt7Evaih_yZ-OIzDaAC_Wwep_U35_Pd8oPwFzuYsr</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Paramsothy, Abira</creator><creator>Lartey Jalloh, Sarah</creator><creator>Davies, Richard A.</creator><creator>Guttormsen, Anne‐Berit</creator><creator>Cox, Rebecca J.</creator><creator>Mohn, Kristin G.‐I.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2304-2786</orcidid><orcidid>https://orcid.org/0000-0002-3249-1719</orcidid></search><sort><creationdate>202108</creationdate><title>Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients</title><author>Paramsothy, Abira ; Lartey Jalloh, Sarah ; Davies, Richard A. ; Guttormsen, Anne‐Berit ; Cox, Rebecca J. ; Mohn, Kristin G.‐I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-5bdf4bbd822ce67affa245771ea773e6828ca7ba823e42961894d9b3d4cb32b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>Antibody response</topic><topic>Avidity</topic><topic>CD4 antigen</topic><topic>CD8 antigen</topic><topic>critical illness</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>Epitopes</topic><topic>Exo-a-sialidase</topic><topic>Glycoproteins</topic><topic>Hemagglutination inhibition</topic><topic>Hemagglutinins</topic><topic>immune response</topic><topic>Immune response (cell-mediated)</topic><topic>Immune response (humoral)</topic><topic>Immunoglobulin G</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>influenza A/H1N1</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paramsothy, Abira</creatorcontrib><creatorcontrib>Lartey Jalloh, Sarah</creatorcontrib><creatorcontrib>Davies, Richard A.</creatorcontrib><creatorcontrib>Guttormsen, Anne‐Berit</creatorcontrib><creatorcontrib>Cox, Rebecca J.</creatorcontrib><creatorcontrib>Mohn, Kristin G.‐I.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paramsothy, Abira</au><au>Lartey Jalloh, Sarah</au><au>Davies, Richard A.</au><au>Guttormsen, Anne‐Berit</au><au>Cox, Rebecca J.</au><au>Mohn, Kristin G.‐I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients</atitle><jtitle>Scandinavian journal of immunology</jtitle><addtitle>Scand J Immunol</addtitle><date>2021-08</date><risdate>2021</risdate><volume>94</volume><issue>2</issue><spage>e13045</spage><epage>n/a</epage><pages>e13045-n/a</pages><issn>0300-9475</issn><eissn>1365-3083</eissn><abstract>There is limited knowledge of influenza‐specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to more severe illness. We followed 12 patients hospitalized with severe influenza infection; the majority admitted to intensive care unit (ICU). Blood samples were collected at days 10 and 19 and at 5 months. Antibody responses to surface glycoproteins haemagglutinin (HA) and neuraminidase (NA) of A/H1N1pdm09 were quantified by haemagglutination inhibition (HAI), microneutralization (MN), Enzyme‐linked immunosorbent assay (ELISA) and Enzyme‐linked lectin assay (ELLA). Influenza‐specific antibody levels and avidity were measured separately for head and stalk domains of H1. Cytokine secreting CD4+ and CD8+ T cell responses to conserved influenza epitopes (M1, NP and PB1) were analysed by FluoroSpot. Overall, the patients retained a high level of functional HA‐ and NA‐specific antibodies over the study period. During the acute phase (up to 3 weeks from symptom onset), antibodies specific to H1 stalk increased earlier and were present in higher amount compared with H1 head‐specific antibodies. The NA‐specific antibodies and the non‐neutralizing HA‐specific antibody response for H1 head and H1 full‐length showed a significant decline from acute to convalescent phase. Despite high total IgG concentrations, avidity to H1 head and H1 full‐length protein remained low at all time points. Similarly, CD8+ T cell responses were continuously measured at low levels. In conclusion, our study found that critically ill patients were characterized by low HA‐specific antibody avidity and CD8+ T cell response.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33891354</pmid><doi>10.1111/sji.13045</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-2304-2786</orcidid><orcidid>https://orcid.org/0000-0002-3249-1719</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0300-9475
ispartof Scandinavian journal of immunology, 2021-08, Vol.94 (2), p.e13045-n/a
issn 0300-9475
1365-3083
language eng
recordid cdi_proquest_miscellaneous_2518221040
source Access via Wiley Online Library; Wiley Free Content; EZB-FREE-00999 freely available EZB journals
subjects Antibodies
Antibody response
Avidity
CD4 antigen
CD8 antigen
critical illness
Enzyme-linked immunosorbent assay
Enzymes
Epitopes
Exo-a-sialidase
Glycoproteins
Hemagglutination inhibition
Hemagglutinins
immune response
Immune response (cell-mediated)
Immune response (humoral)
Immunoglobulin G
Influenza
Influenza A
influenza A/H1N1
Lymphocytes
Lymphocytes T
title Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T19%3A55%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Humoral%20and%20cellular%20immune%20responses%20in%20critically%20ill%20influenza%20A/H1N1%E2%80%90infected%20patients&rft.jtitle=Scandinavian%20journal%20of%20immunology&rft.au=Paramsothy,%20Abira&rft.date=2021-08&rft.volume=94&rft.issue=2&rft.spage=e13045&rft.epage=n/a&rft.pages=e13045-n/a&rft.issn=0300-9475&rft.eissn=1365-3083&rft_id=info:doi/10.1111/sji.13045&rft_dat=%3Cproquest_cross%3E2518221040%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2552119988&rft_id=info:pmid/33891354&rfr_iscdi=true